Ameritas Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,590	Closed	-$389K	–	2970
2025 Q2	$389K	Sell	9,590 -229	-2%	-$9.21K	0.02%	566
2025 Q1	$430K	Sell	9,819 -193	-2%	-$8.52K	0.02%	605
2024 Q4	$430K	Buy	10,012 +146	+1%	+$6.64K	0.01%	628
2024 Q3	$438K	Sell	9,866 -715	-7%	-$30.6K	0.02%	575
2024 Q2	$421K	Sell	10,581 -340	-3%	-$13.8K	0.02%	631
2024 Q1	$471K	Sell	10,921 -3,397	-24%	-$146K	0.02%	569
2023 Q4	$596K	Buy	14,318 +925	+7%	+$35K	0.03%	392
2023 Q3	$532K	Buy	+13,393	New	+$567K	0.03%	487
2023 Q2	–	Sell	-11,339	Closed	-$480K	–	2559
2023 Q1	$480K	Buy	11,339 +57	+0.5%	+$2.4K	0.02%	484
2022 Q4	$462K	Sell	11,282 -1,528	-12%	-$63.6K	0.02%	557
2022 Q3	$514K	Sell	12,810 -314	-2%	-$13.4K	0.03%	426
2022 Q2	$551K	Sell	13,124 -1,474	-10%	-$61.8K	0.03%	427
2022 Q1	$661K	Buy	14,598 +1,306	+10%	+$57.4K	0.02%	433
2021 Q4	$613K	Buy	+13,292	New	+$630K	0.02%	447